Immunohistochemical localization of cerebrovascular cannabinoid CB1 receptor protein

被引:18
作者
Ashton, JC [1 ]
Appleton, I [1 ]
Darlington, CL [1 ]
Smith, PF [1 ]
机构
[1] Univ Otago, Sch Med, Sch Med Sci, Dept Pharmacol & Toxicol, Dunedin, New Zealand
关键词
cannabinoid; CB1 receptor protein; cerebrovascular; hypotension; vascular smooth muscle; vasodilation;
D O I
10.1097/00005344-200411000-00001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cannabinoids are powerful hypotensives and vasodilators. However, their mode of action is controversial. This study is the first to investigate the distribution of vascular CB1 receptor protein expression in situ. We used double-fluorescence and chromogenic immunohistochemistry to investigate patterns of CB1 protein expression in cerebrovascular tissue in rat brain sections. We found a layer of intense CB1 labeling immediately adjacent to the internal elastic lamina, consistent with myointimal and vascular smooth muscle cells, and diffuse labeling adventitial to this layer. We concluded that CB1 receptor are most intensely expressed in the vascular smooth muscle layer in cerebral arteries, and are likely to be chiefly responsible for the potent vasodilatory effect of cannabinoids.
引用
收藏
页码:517 / 519
页数:3
相关论文
共 17 条
[1]   Cannabinoid CB1 receptor protein expression in the rat choroid plexus: a possible involvement of cannabinoids in the regulation of cerebrospinal fluid [J].
Ashton, JC ;
Appleton, I ;
Darlington, CL ;
Smith, PF .
NEUROSCIENCE LETTERS, 2004, 364 (01) :40-42
[2]   Endocannabinoids acting at vascular CB, receptors mediate the vasodilated state in advanced liver cirrhosis [J].
Bátkai, S ;
Járat, Z ;
Wagner, JA ;
Goparaju, SK ;
Varga, K ;
Liu, J ;
Wang, L ;
Mirshahi, F ;
Khanolkar, AD ;
Makriyannis, A ;
Urbaschek, R ;
Garcia, N ;
Sanyal, AJ ;
Kunos, G .
NATURE MEDICINE, 2001, 7 (07) :827-832
[3]   The neurobiology and evolution of cannabinoid signalling [J].
Elphick, MR ;
Egertová, M .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2001, 356 (1407) :381-408
[4]   Inhibition of the production of endothelium-derived hyperpolarizing factor by cannabinoid receptor agonists [J].
Fleming, I ;
Schermer, B ;
Popp, R ;
Busse, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (04) :949-960
[5]  
GEBREMEDHIN D, 1999, AM J PHYSIOL, V276, P85
[6]   Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed [J].
Harris, D ;
McCulloch, AI ;
Kendall, DA ;
Randall, MD .
JOURNAL OF PHYSIOLOGY-LONDON, 2002, 539 (03) :893-902
[7]  
Hillard CJ, 2000, J PHARMACOL EXP THER, V294, P27
[8]   Cardiovascular pharmacology of anandamide [J].
Högestätt, ED ;
Zygmunt, PM .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2002, 66 (2-3) :343-351
[9]   The quest for a vascular endothelial cannabinoid receptor [J].
Kunos, G ;
Bátkai, S ;
Offertáler, L ;
Mo, F ;
Liu, J ;
Karcher, J ;
Harvey-White, J .
CHEMISTRY AND PHYSICS OF LIPIDS, 2002, 121 (1-2) :45-56
[10]   Cardiovascular effects of endocannabinoids -: the plot thickens [J].
Kunos, G ;
Járai, Z ;
Varga, K ;
Liu, J ;
Wang, L ;
Wagner, JA .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2000, 61 (1-2) :71-84